Categories AlphaGraphs, Earnings, Health Care
A graphical representation of Abbott Laboratories (ABT) Q1 2020 earnings results
Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today.
The company reported a 16% drop in earnings for the first quarter of 2020 due to tax expense despite a 2.5% increase in the top-line. Abbott is suspending its previously announced annual guidance for 2020 due to uncertainties regarding the duration and impact of the coronavirus (COVID-19) pandemic.
Abbott launched three critical new tests for COVID-19, two molecular tests and one serology blood test for the detection of the antibody. While molecular testing detects whether someone has the virus, antibody tests determine if someone was previously infected.
Past Performance
Most Popular
Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results, with market watchers forecasting a mixed outcome. As part of
Chewy (CHWY) is set for meaningful growth in the coming year, here’s why
Shares of Chewy, Inc. (NYSE: CHWY) stayed red on Thursday. The stock has dropped 2% over the past three months. The pet products company ended fiscal year 2024 on a
GME Earnings: GameStop Q4 2024 profit rises; sales down 28%
Video game company GameStop Corp. (NYSE: GME) has reported an increase in fourth-quarter 2024 earnings, despite a double-digit fall in revenues. Net sales decreased to $1.28 billion in the fourth
